Clinical Trial

Daily Iron vs Every-other-day Iron for Pediatric Patients With IDA

Not Yet Recruiting Phase 4
View on ClinicalTrials.gov →
Summary
Iron Deficiency Anemia (IDA) is a prevalent global health issue affecting a significant proportion of the population, including children. While daily oral iron supplementation is a common approach to treat IDA, concerns regarding side effects and compliance have led to exploration of alternative dosing schedules, such as every-other-day. This study aims to investigate the efficacy and safety of daily versus every other day oral iron supplementation in the management of IDA in pediatric patients.
Protocol Amendment History 6 amendments
This ClinicalTrials.gov record has been amended 6 times since 2024-08-09; most recent amendment 2026-07-08.
Trial Details
NCT Number NCT06550362
Lead Sponsor Loma Linda University
Conditions Iron Deficiency Anemia
Enrollment 100 participants
Start Date 2026-12
Primary Completion 2027-05 (estimated)
Study Completion 2027-05 (estimated)
Updated on ClinicalTrials.gov 2026-07-10